Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06115486 · ClinicalTrials.gov registry record · NA

EXERT-BCH Exercise Regimen to Improve Muscle Mass After Treatment of Breast Cancer

A NA study of Breast Cancer and Breast Cancer Female, sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute).

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06115486 is a NA study of Breast Cancer and Breast Cancer Female that is actively recruiting participants, run by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute). The registered enrollment target is 30 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06115486, a NA study of Breast Cancer and Breast Cancer Female, is actively recruiting participants, sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute).

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to evaluate the outcomes of two standard of care group exercise regimens to increase muscle mass in women who have been treated with breast cancer.

Interventions

  • OTHER Control Arm ACSM Guidelines
  • OTHER Experimental Arm 6-12-25 repetitions per set

Study Locations (1)

Pennsylvania

  • Allegheny General Hospital - Pittsburgh

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2024-01-09
Est. Completion 2027-01
Phase NA

What the Registry Record Tells You About NCT06115486

The ClinicalTrials.gov registry entry for NCT06115486 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The listed sponsor is Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute), which has 34 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which Control Arm ACSM Guidelines is the first listed.

NCT06115486 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06115486 about?

NCT06115486 is a clinical study titled "EXERT-BCH Exercise Regimen to Improve Muscle Mass After Treatment of Breast Cancer". The purpose of this research study is to evaluate the outcomes of two standard of care group exercise regimens to increase muscle mass in women who have been treated with breast cancer.

What is the current status of trial NCT06115486?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-01-09. Estimated completion is 2027-01.

What conditions does trial NCT06115486 study?

This clinical trial studies the following conditions: Breast Cancer, Breast Cancer Female, Breast Carcinoma in Situ.

What interventions are being tested in trial NCT06115486?

The interventions under investigation include: Control Arm ACSM Guidelines (OTHER), Experimental Arm 6-12-25 repetitions per set (OTHER).

Who is sponsoring clinical trial NCT06115486?

This trial is sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute), which has 34 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06115486 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.